EX-10.58
Eloxx Pharmaceuticals, Inc.
Exhibit 10.58
ELOXX PHARMACEUTICALS, INC.
AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN
ADOPTED BY THE BOARD OF DIRECTORS: APRIL 28, 2026
APPROVED BY THE STOCKHOLDERS: APRIL 28, 2026
EFFECTIVE DATE: APRIL 28, 2026
| 1. | GENERAL. |
(a) Plan History. The Eloxx Pharmaceuticals, Inc. 2018 Equity Incentive Plan (the “2018 Plan”) was first adopted by the Board on March 12, 2018 and approved by our stockholders on March 26, 2018 (the “Original Effective Date”). On September 19, 2025, it was amended to increase the Share Reserve and aggregate Incentive Stock Option limit. As of the Effective Date, the 2018 Plan was amended and restated (as amended and restated, the “Plan”) to extend the term of the 2018 Plan and to make certain other clarifying and administrative amendments thereto.
(b) Eligible Award Recipients. Employees, Directors and Consultants are eligible to receive Awards.
…